secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001493152-25-018054
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters Series C Preferred Stock financing with Hexstone Capital
--------------------------------------------------------------------------------

- Issues 100 shares of Series C Preferred convertible at lesser of $5.00 fixed or 85% of lowest trading price over conversion period.
- Warrant issued to purchase up to 9,900 additional Series C shares at $10,000 per warrant share.
- Company reserves shares equal to 200% of maximum conversion shares; closing subject to filing Certificate of Designation with Delaware.
- Transaction includes Voting Agreement with officers/directors and Registration Rights Agreement for warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/0001493152-25-018054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer